Differential antibacterial activity against pseudomonas aeruginosa by carbon monoxide-releasing molecules

Antioxidants and Redox Signaling

Volumn 16, Issue 2, 2012, Pages 153-163

  Desmard, Mathieu ^a,b   Foresti, Roberta ^c   Morin, Didier ^a   Dagoussat, Maylis ^a   Berdeaux, Alain ^a   Denamur, Erick ^d   Crook, Sian H ^e   Mann, Brian E ^e   Scapens, David ^e   Montravers, Philippe ^b   Boczkowski, Jorge ^a,f,g   Motterlini, Roberto ^a,c  

^a UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^b BICHAT HOSPITAL   (France)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^d INSERM   (France)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

^f HENRI MONDOR HOSPITAL   (France)

^g CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ANTIBIOTIC AGENT; CARBON MONOXIDE; CARBON MONOXIDE RELEASING MOLECULE; CARBONIC ACID; MANGANESE DERIVATIVE; REACTIVE OXYGEN METABOLITE; RUTHENIUM DERIVATIVE; SODIUM; SODIUM BORANOCARBONATE; TRICARBONYLDICHLORORUTHENIUM DIMER; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

ACETYLCYSTEINE; ANIMALS; ANTI-BACTERIAL AGENTS; CARBON MONOXIDE; CELLS, CULTURED; HUMANS; MICE; MICROBIAL SENSITIVITY TESTS; OXYGEN; PSEUDOMONAS AERUGINOSA; REACTIVE OXYGEN SPECIES;

BACTERIA (MICROORGANISMS); MURINAE; MUS; PSEUDOMONAS AERUGINOSA;

EID: 81755178436     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.3959     Document Type: Article

References (46)

1. Alberto R and Motterlini R. Chemistry and biological activities of CO-releasing molecules (CORMs) and transition metal complexes. Dalton Trans 1651-1660, 2007. (Pubitemid 46633110)
2. Amara N, Goven D, Prost F, Muloway R, Crestani B, and Boczkowski J. NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idiopathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts. Thorax 65: 733-738, 2010.
3. Andre L, Boissiere J, Reboul C, Perrier R, Zalvidea S, Meyer G, Thireau J, Tanguy S, Bideaux P, HayotM, Boucher F, Obert P, Cazorla O, and Richard S. Carbon monoxide pollution promotes cardiac remodeling and ventricular arrhythmia in healthy rats. Am J Respir Crit Care Med 181: 587-595, 2010.
4. Anthonysamy A, Balasubramanian S, Shanmugaiah V, and Mathivanan N. Synthesis, characterization and electrochemistry of 4'-functionalized 2,2':6',2"-terpyridine ruthenium( II) complexes and their biological activity. Dalton Trans 2136-2143, 2008. (Pubitemid 351509362)
5. Bilban M, Haschemi A, Wegiel B, Chin BY, Wagner O, and Otterbein LE. Heme oxygenase and carbon monoxide initiate homeostatic signaling. J Mol Med 86: 267-279, 2008.
6. Boczkowski J, Poderoso JJ, and Motterlini R. CO-metal interaction: vital signaling from a lethal gas. Trends Biochem Sci 31: 614-621, 2006. (Pubitemid 44740399)
7. Chin BY and Otterbein LE. Carbon monoxide is a poison. to microbes! CO as a bactericidal molecule. Curr Opin Pharmacol 9: 490-500, 2009.
8. Clark JE, Green CJ, and Motterlini R. Involvement of the heme oxygenase-carbon monoxide pathway in keratinocyte proliferation. Biochem Biophys Res Commun 241: 215-220, 1997. (Pubitemid 28020082)
9. Clark JE, Naughton P, Shurey S, Green CJ, Johnson TR, Mann BE, Foresti R, and Motterlini R. Cardioprotective actions by a water-soluble carbon monoxide-releasing molecule. Circ Res 93: e2-e8, 2003.
10. Davidge KS, Motterlini R, Mann BE, Wilson JL, and Poole RK. Carbon monoxide in biology and microbiology: surprising roles for the "Detroit Perfume." Adv Microbiol Physiol 56: 85-167, 2009.
11. Davidge KS, Sanguinetti G, Yee CH, Cox AG, McLeod CW, Monk CE, Mann BE, Motterlini R, and Poole RK. Carbon monoxide-releasing antibacterial molecules target respiration and global transcriptional regulators. J Biol Chem 284: 4516-4524, 2009.
12. De Backer O, Elinck E, Blanckaert B, Leybaert L, Motterlini R, and Lefebvre RA. Water-soluble CO-releasing molecules (CO-RMs) reduce the development of postoperative ileus via modulation of MAPK/HO-1 signaling and reduction of oxidative stress. Gut 58: 347-356, 2009.
13. Desmard M, Boczkowski J, Poderoso J, and Motterlini R. Mitochondrial and cellular heme-dependent proteins as targets for the bioactive function of the heme oxygenase/carbon monoxide system. Antioxid Redox Signal 9: 2139-2155, 2007. (Pubitemid 350059023)
14. Desmard M, Davidge KS, Bouvet O, Morin D, Roux D, Foresti R, Ricard JD, Denamur E, Poole RK, Montravers P, Motterlini R, and Boczkowski J. A carbon monoxide-releasing molecule (CORM-3) exerts bactericidal activity against Pseudomonas aeruginosa and improves survival in an animal model of bacteraemia. FASEB J 23: 1023-1031, 2009.
15. Fairlamb IJ, Lynam JM, Moulton BE, Taylor IE, Duhme-Klair AK, Sawle P, and Motterlini R. h(1)-2-Pyrone metal carbonyl complexes as CO-releasing molecules (CO-RMs): a delicate balance between stability and CO liberation. Dalton Trans 3603-3605, 2007. (Pubitemid 47258193)
16. Flamm RK, Weaver MK, Thornsberry C, Jones ME, Karlowsky JA, and Sahm DF. Factors associated with relative rates of antibiotic resistance in Pseudomonas aeruginosa isolates tested in clinical laboratories in the United States from 1999 to 2002. Antimicrob Agents Chemother 48: 2431-2436, 2004. (Pubitemid 38823407)
17. Foresti R, Bani-Hani MG, and Motterlini R. Use of carbon monoxide as a therapeutic agent: promises and challenges. Intensive Care Med 34: 649-658, 2008.
18. Gorman D, Drewry A, Huang YL, and Sames C. The clinical toxicology of carbon monoxide. Toxicology 187: 25-38, 2003. (Pubitemid 36385053)
19. Hasegawa U, van der Vlies AJ, Simeoni E, Wandrey C, and Hubbell JA. Carbon monoxide-releasing micelles for immunotherapy. J Am Chem Soc 132: 18273-18280, 2010.
20. Kondo-Nakamura M, Shintani-Ishida K, Uemura K, and Yoshida K. Brief exposure to carbon monoxide preconditions cardiomyogenic cells against apoptosis in ischemiareperfusion. Biochem Biophys Res Commun 393: 449-454, 2010.
21. Kretschmer R, Gessner G, Gorls H, Heinemann SH, and Westerhausen M. Dicarbonyl-bis(cysteamine)iron(II): a light induced carbon monoxide releasing molecule based on iron (CORM-S1). J Inorg Biochem 105: 6-9, 2011.
22. Lancel S, Hassoun SM, Favory R, Decoster B, Motterlini R, and Neviere R. Carbon monoxide rescues mice from lethal sepsis by supporting mitochondrial energetic metabolism and activating mitochondrial biogenesis. J Pharmacol Exp Ther 1329: 641-648, 2009.
23. Mann BE and Motterlini R. CO and NO in medicine. Chem Commun 41: 4208, 2007.
24. Motterlini R. Carbon monoxide-releasing molecules (CORMs): vasodilatory, anti-ischemic and anti-inflammatory activities. Biochem Soc Trans 35: 1142-1146, 2007. (Pubitemid 350214248)
25. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, and Green CJ. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 90: E17-E24, 2002.
26. Motterlini R and Otterbein LE. Therapeutic potential of carbon monoxide. Nat Rev Drug Discov 9: 728-743, 2010.
27. Motterlini R, Sawle P, Bains S, Hammad J, Alberto R, Foresti R, and Green CJ. CORM-A1: a new pharmacologically active carbon monoxide-releasing molecule. FASEB J 19: 284-286, 2005. (Pubitemid 40189283)
28. Nobre LS, Al Shahrour F, Dopazo J, and Saraiva LM. Exploring the antimicrobial action of a carbon monoxidereleasing compound through whole-genome transcription profiling of Escherichia coli. Microbiology 155: 813-824, 2009.
29. Nobre LS, Seixas JD, Romao CC, and Saraiva LM. Antimicrobial action of carbon monoxide-releasing compounds. Antimicrob Agents Chemother 51: 4303-4307, 2007. (Pubitemid 350209881)
30. Obirai JC, Hamadi S, Ithurbide A, Wartelle C, Nyokong T, Zagal J, Top S, and Bedioui F. UV-Visible and electrochemical monitoring of carbon monoxide release by donor complexes to myoglobin solutions and to electrodes modified with films containing hemin. Electroanalyis 1689-1695, 2006.
31. Ortiz de Montellano PR. The mechanism of heme oxygenase. Curr Opin Chem Biol 4: 221-227, 2000. (Pubitemid 30189315)
32. Pitchumony TS, Spingler B, Motterlini R, and Alberto R. Syntheses, structural characterization and CO releasing properties of boranocarbonate [H(3)BCO(2)H](-) derivatives. Org Biomol Chem 8: 4849-4854, 2010.
33. Ryter SW, Alam J, and Choi AM. Heme oxygenase-1/carbon monoxide: from basic science to therapeutic applications. Physiol Rev 86: 583-650, 2006.
34. Sawada M, Nakashima S, Kiyono T, Nakagawa M, Yamada J, Yamakawa H, Banno Y, Shinoda J, Nishimura Y, Nozawa Y, and Sakai N. p53 regulates ceramide formation by neutral sphingomyelinase through reactive oxygen species in human glioma cells. Oncogene 20: 1368-1378, 2001. (Pubitemid 32269941)
35. Sawle P, Foresti R, Mann BE, Johnson TR, Green CJ, and Motterlini R. Carbon monoxide-releasing molecules (CORMs) attenuate the inflammatory response elicited by lipopolysaccharide in RAW264.7 murine macrophages. Br J Pharmacol 145: 800-810, 2005. (Pubitemid 41076287)
36. Sawle P, Hammad J, Fairlamb IJ, Moulton B, O'Brien CT, Lynam JM, Duhme-Klair AK, Foresti R, and Motterlini R. Bioactive properties of iron-containing carbon monoxidereleasing molecules (CO-RMs). J Pharmacol Exp Ther 318: 403-410, 2006.
37. Srisook K, Han SS, Choi HS, Li MH, Ueda H, Kim C, and Cha YN. CO from enhanced HO activity or from CORM-2 inhibits both O2-and NO production and downregulates HO-1 expression in LPS-stimulated macrophages. Biochem Pharmacol 71: 307-318, 2006. (Pubitemid 41817291)
38. Suliman HB, Carraway MS, Tatro LG, and Piantadosi CA. A new activating role for CO in cardiac mitochondrial biogenesis. J Cell Sci 120: 299-308, 2006.
39. Taille C, El-Benna J, Lanone S, Boczkowski J, and Motterlini R. Mitochondrial respiratory chain and NAD(P)H oxidase are targets for the antiproliferative effect of carbonmonoxide in human airway smooth muscle. J Biol Chem280: 25350-25360, 2005. (Pubitemid 40962237)
40. Takamiya R, Hung CC, Hall SR, Fukunaga K, Nagaishi T, Maeno T, Owen C, Macias AA, Fredenburgh LE, Ishizaka A, Blumberg RS, Baron RM, and Perrella MA. High mobility group Box 1 contributes to lethality of endotoxemia in heme oxygenase-1 deficient mice. Am J Respir Cell Mol Biol 41: 129-135, 2008.
41. Tarricone E, Scapin C, Vitadello M, Esposito F, Margonato V, Milano G, Samaja M, and Gorza L. Cellular distribution of Hsp70 expression in rat skeletal muscles. Effects of moderate exercise training and chronic hypoxia. Cell Stress Chaperones 13: 483-495, 2008.
42. Tayem Y, Johnson TR, Mann BE, Green CJ, and Motterlini R. Protection against cisplatin-induced nephrotoxicity by a carbon monoxide-releasing molecule. Am J Physiol Renal Physiol 290: F789-F794, 2006. (Pubitemid 43724937)
43. Vesely MJJ, Exon DJ, Clark JE, Foresti R, Green CJ, and Motterlini R. Heme oxygenase-1 induction in skeletal muscle cells: hemin and sodium nitroprusside are regulators in vitro. Am J Physiol 275: C1087-C1094, 1998.
44. Yi L, Morgan JT, and Ragsdale SW. Identification of a thiol/disulfide redox switch in the human BK channel that controls its affinity for heme and CO. J Biol Chem 285: 20117-20127, 2010.
45. Zhang J and Piantadosi CA. Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain. J Clin Invest 90: 1193-1199, 1992.
46. Zuckerbraun BS, Chin BY, Bilban M, de Costa dJ, Rao J, Billiar TR, and Otterbein LE. Carbon monoxide signals via inhibition of cytochrome c oxidase and generation of mitochondrial reactive oxygen species. FASEB J 21: 1099-1106, 2007. (Pubitemid 46495699)